PDS Biotechnology CEO's 16.6M options need approval
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PDS Biotechnology Corp President and CEO Frank Bedu-Addo was granted two employee stock-option awards on November 16, 2026: 2,698,978 options, fully vested and exercisable, and 16,556,733 options, subject to stockholder approval of the company’s 2026 Equity Incentive Plan. Both awards have an exercise price of $0.9241 and expire November 16, 2036. The larger award is not exercisable before approval and, if approved, vests in equal monthly installments over four years beginning December 16, 2026, subject to continued service. If approval is not obtained under the grant terms, that option is to be surrendered for cancellation.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) F1 | 2,698,978 | $0.00 | $0.00 |
| Grant/Award | Employee Stock Option (Right to Buy) F2 | 16,556,733 | $0.00 | $0.00 |
Footnotes (2)
- F1. The option is fully vested and exercisable.
- F2. The option was granted on November 16, 2026, subject to stockholder approval of the Issuer's 2026 Equity Incentive Plan under Nasdaq Marketplace Rule 5635(c). The option is not exercisable until stockholder approval has been obtained. Contingent upon stockholder approval, the shares subject to the option shall vest in equal monthly installments over four (4) years, beginning on December 16, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date. In the event stockholder approval is not obtained pursuant to the terms of grant, then the Reporting Person shall surrender the option to the Company for cancellation.
Key Figures
Key Terms
fully vested and exercisable technical
stockholder approval regulatory
Nasdaq Marketplace Rule 5635(c) regulatory
vest in equal monthly installments technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When does the 16,556,733-option PDSB award vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.